ライフサイエンスコーパス: Lactobacillus

1 reases in Coriobacteriaceae, Clostridium and Lactobacillus.

2 ty, six yet unknown putative bacteriocins in Lactobacillus.

3 t microbial community such as a reduction in Lactobacillus.

4 tissue and was correlated with abundance of Lactobacillus.

5 The increased spleen levels of Lactobacillus 16S rRNA in SDR mice positively correlated

6 l bacterial community types-one dominated by Lactobacillus (59.2%) and the other where Gardnerella va

7 iomarkers were also negatively correlated to Lactobacillus abundance and positively correlated with a

8 al LB supplementation, carried out by giving Lactobacillus acidophilus and Bifidobacterium infantis (

9 oward well-known probiotic bacteria, such as Lactobacillus acidophilus and Lactobacillus plantarum, w

10 hromosomal integration method, we engineered Lactobacillus acidophilus ATCC 4356 to display human CD4

11 re of six viable strains including 107 mg of Lactobacillus acidophilus BCMC(R) 12,130, Lactobacillus

12 xtracts, some increasing 1.4-2 Log cycles of Lactobacillus acidophilus La-5 and Bifidobacterium anima

13 coccus gordonii, Actinomyces naeslundii, and Lactobacillus acidophilus), in planktonic cells or biofi

14 estinal bacterial species (Escherichia coli, Lactobacillus acidophilus, Bifidobacterium animalis subs

15 gs demonstrate that the protective effect of Lactobacillus against HIV-1 is, in part, mediated by EVs

16 g the numbers of Lactobacillus crispatus and Lactobacillus agilis, and decreasing Lactobacillus saliv

17 es, Escherichia coli, Acinetobacter lwoffii, Lactobacillus amylovorus, and Lactobacillus reuteri domi

18 tics containing six viable microorganisms of Lactobacillus and Bifidobacteria strains are safe to be

19 six viable microorganisms of 30 x 10(10) cfu Lactobacillus and Bifidobacteria strains for six months

20 bundance of potentially protective taxa (eg, Lactobacillus and Clostridiales) and increased risk of E

21 microbiota complexity in cecum by increasing Lactobacillus and decreased Desulfovibrio The net effect

22 ifically, our study implicates urinary tract Lactobacillus and Enterobacteriaceae in protective and p

23 proposed associations between PTB and lower Lactobacillus and higher Gardnerella abundances replicat

24 Specifically, we observed reduced Lactobacillus and increased circulating kynurenine level

25 users, each compared to controls, had higher Lactobacillus and lower BV-anaerobes estimated concentra

26 c Femi+ vaginal capsule (containing multiple Lactobacillus and one Bifidobacterium species), or Gynop

27 Our data revealed that Lactococcus, Lactobacillus, and Coprococcus protect the liver from in

28 group, Corynebacterium, Cutibacterium acnes, Lactobacillus, and Micrococcus), PPA and NPA ranged from

29 5% of the deep-dentin carious samples showed Lactobacillus as the most abundant genus.

30 e middle endometrium, it is not dominated by Lactobacillus as was previously concluded, yet further i

31 14.5% of the top 10 taxa were identified as Lactobacillus at the genus level, only 25% of the deep-d

32 Here we report a markedly higher risk of Lactobacillus bacteremia for intensive care unit (ICU) p

33 Lactobacillus bacteria are potential delivery vehicles f

34 report provides a proof-of-concept by using Lactobacillus bacteria stably expressing the HIV-1 recep

35 n but only 18% (P = 0.644) in women with non-Lactobacillus bacteria, a threefold difference in effica

36 ifferential gut microbial composition (e.g., Lactobacillus, Bacteroides, and Enterobacteriaceae) and

37 bumble bee microbes - Snodgrassella alvi and Lactobacillus bombicola - in selenate-spiked media and f

38 Here we report the in vivo application of Lactobacillus brevis (Lb)NOX(1), a bacterial water-formi

39 NAD+ by expression of the NADH oxidase from Lactobacillus brevis (LbNOX)(13) targeted to the mitocho

40 re of an EPS isolated from sourdough isolate Lactobacillus brevis E25 was determined.

41 Lactobacillus brevis POM, and Lactobacillus plantarum (T

42 er how an enzyme from specific gut bacteria (Lactobacillus brevis) regulates locomotor behavior throu

43 h of Bifidobacterium adolescentis but not of Lactobacillus brevis.

44 d in representatives of the S24-7 family and Lactobacillus but enriched with Bacteroides and Parabact

45 ological (lactic acid bacteria and probiotic Lactobacillus casei 01 counts and survival under gastroi

46 at the general acid/base residue E274 of the Lactobacillus casei alpha1,6-fucosidase, including E274A

47 lation (Lactobacillus plantarum CECT 220 and Lactobacillus casei CECT 475) in order to evaluate the a

48 aim of the study is to evaluate the role of Lactobacillus casei DG (LC-DG) and its postbiotic (PB) i

49 Chickens were given Lactobacillus casei over-expressing myosin-cross-reactiv

50 Lactobacillus casei produces an alpha-fucosidase, called

51 12,130, Lactobacillus lactis BCMC(R) 12,451, Lactobacillus casei subsp BCMC(R) 12,313, Bifidobacteriu

52 ta, a Chilean native berry, impregnated with Lactobacillus casei var. rhamnosus and dehydrated by dif

53 nd dysbiosis, featured by decreased level of Lactobacillus casei, Lactobacillus johnsonii and increas

54 vity was noted with Streptococcus mutans and Lactobacillus casei.

55 a pathogenic Listeria (Lm) on the surface of Lactobacillus casei.

56 We validate results in Gardnerella and Lactobacillus co-cultures, and in two clinical cohorts,

57 kimchii, Lactococcus lactis subsp. cremoris, Lactobacillus coryniformis subsp. coryniformis, Lactobac

58 lts show that pre-treatment using species of Lactobacillus could be utilised to alter the quality of

59 2%]), Lactobacillus iners (n = 32 [34%]), or Lactobacillus crispatus (n = 22 [24%]).

60 Trimo-San) significantly inhibited growth of Lactobacillus crispatus (p < 0.01), while the product Re

61 actobacillus reuteri, Enterococcus faecalis, Lactobacillus crispatus and Clostridium orbiscindens) pr

62 ibited significantly lower vaginal levels of Lactobacillus crispatus and higher levels of BVAB1, Snea

63 bial population by increasing the numbers of Lactobacillus crispatus and Lactobacillus agilis, and de

64 d, phase 2b trial to evaluate the ability of Lactobacillus crispatus CTV-05 (Lactin-V) to prevent the

65 Lactobacillus crispatus demonstrated less growth inhibit

66 Vaginal community dominance by Lactobacillus crispatus or L. gasseri was more common in

67 Lactobacillus crispatus was the numerically most abundan

68 chromosomal targeting and genome editing in Lactobacillus crispatus, an important commensal and bene

69 ajor community state types with abundance of Lactobacillus crispatus, Lactobacillus iners, and a dive

70 the proportion of lactobacilli species (ie, Lactobacillus crispatus, Lactobacillus iners, Lactobacil

71 reased frequencies of Lactobacillus reuteri, Lactobacillus crispatus, Lactobacillus jensenii, and Lac

72 ucosal CD4(+) T cells compared to those with Lactobacillus crispatus-dominant communities.

73 of vaginal epithelial cells is associated to Lactobacillus crispatus-dominated microbiota.

74 growth and viability of Escherichia coli and Lactobacillus crispatus.

75 ) of persistent hrHPV compared to women with Lactobacillus deficient microbiota.

76 4 was neither associated with Nugent-BV nor Lactobacillus-deficient microbiota (OR, 1.49; 95% CI, 0.

77 5% CI, 4.36-20.73) were also associated with Lactobacillus-deficient vaginal microbiota.

78 en strains (9 Lactobacillus helveticus and 6 Lactobacillus delbrueckii subsp. bulgaricus) were then s

79 However, in women with a Lactobacillus-depleted, high-diversity VM, significantly

80 More than 80 protein components from Lactobacillus-derived MVs were identified, including som

81 Mechanistically, we identified that Lactobacillus-derived reactive oxygen species may suppre

82 with the decreased abundance of Clostridium, Lactobacillus, Desulfovibrio, and Methylobacterium and a

83 nd 78% specificity in distinguishing between Lactobacillus dominance and BV, as determined by Nugent

84 infected with hrHPV was higher in women with Lactobacillus dominant microbiota (OR: 1.25, 95% CI 0.73

85 In HIV-negative women, women with Lactobacillus dominant microbiota had lower odds (OR: 0.

86 Within the non-Lactobacillus-dominant CST IV, GBS positive status was s

87 We show that women with a Lactobacillus-dominant microbiome at baseline are more l

88 reproductive tract (FRT) in which a healthy Lactobacillus-dominant microflora is replaced by BV-asso

89 outcomes and characterized by a shift from a Lactobacillus-dominant vaginal microbiota to a polymicro

90 nt results regarding the distinction between Lactobacillus-dominant versus mixed microbiota, reassuri

91 ation, elevated vaginal pH and dysbiotic non-Lactobacillus-dominant VMB, that have been associated wi

92 reduced HIV incidence by 61% (P = 0.013) in Lactobacillus-dominant women but only 18% (P = 0.644) in

93 l microbiome shifted during pregnancy toward Lactobacillus-dominated profiles at the expense of taxa

94 differentiating patterns between AV, BV, and Lactobacillus-dominated vaginal microbiomes.

95 were shown to be elevated in women with non-Lactobacillus-dominated vaginal microbiomes.

96 enriched in Bifidobacterium and depleted of Lactobacillus, Enterococcus, and Lachnospira.

97 Lactobacillus, Escherichia, and Bacteroides bacteriophag

98 tochthonous Lactobacillus plantarum AFI5 and Lactobacillus fabifermentans ALI6 used singly or as bina

99 recently completed sequence of the genome of Lactobacillus fermentum 3872.

100 A human origin Lactobacillus fermentum SR4 and Lactobacillus rhamnosus

101 symbiosum, Faecalibacterium prausnitzii, and Lactobacillus fermentum) for transplantation.

102 We show here that Lactobacillus fermentum, one of the main probiotics of t

103 his study was to determine whether consuming Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-

104 actobacillus crispatus, Lactobacillus iners, Lactobacillus gasseri, and Lactobacillus jensenii), whic

105 s, Prevotella, Acinetobacter, Treponema, and Lactobacillus genera that were differentially represente

106 uding increased abundance of Bacteroides and Lactobacillus genera.

107 Fifteen strains (9 Lactobacillus helveticus and 6 Lactobacillus delbrueckii

108 tide profile in yogurts, and the addition of Lactobacillus helveticus LH-B02 favored the formation of

109 e effect of protein content, the addition of Lactobacillus helveticus LH-B02, and storage time were e

110 iotic containing Lactobacillus rhamnosus and Lactobacillus helveticus or placebo.

111 n of the cheese and proteolytic strains like Lactobacillus helveticus, are added for flavor improveme

112 f L. reuteri in mice and fecal enrichment of Lactobacillus in a subset of SLE patients.

113 Abundance of Lactobacillus in vaginal swabs was correlated with 3TC-T

114 ng diversity (20/51; 39%) or predominated by Lactobacillus iners (22/51; 42%), L. crispatus (7/51; 14

115 r diverse anaerobic bacteria (n = 39 [42%]), Lactobacillus iners (n = 32 [34%]), or Lactobacillus cri

116 sis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vagi

117 solution and the concomitant colonization by Lactobacillus iners substantially increased several geni

118 ichment of vaginal Gardnerella vaginalis and Lactobacillus iners was associated with increased likeli

119 illus crispatus, Lactobacillus jensenii, and Lactobacillus iners).

120 s with abundance of Lactobacillus crispatus, Lactobacillus iners, and a diverse community type were i

121 CSTs), where most profiles were dominated by Lactobacillus iners, Gardnerella vaginalis or were highl

122 acilli species (ie, Lactobacillus crispatus, Lactobacillus iners, Lactobacillus gasseri, and Lactobac

123 erial vaginosis (BV) and, to some extent, by Lactobacillus iners, the genital Lactobacillus spp. that

124 Lactobacillus iners-dominated communities have been asso

125 effect was related to the restoration of an Lactobacillus iners-dominated microbiota.

126 bacilli dominated microbiota with prevailing Lactobacillus iners.

127 teractions between Gardnerella vaginalis and Lactobacillus involved in efficacy, here we develop an o

128 acy decreases when the relative abundance of Lactobacillus is higher pre-treatment.

129 te production) characteristics of 23 vaginal Lactobacillus isolates from South African women, commerc

130 an improved vaginal probiotic using clinical Lactobacillus isolates.

131 tobacillus iners, Lactobacillus gasseri, and Lactobacillus jensenii), which are essential for the gen

132 tobacillus reuteri, Lactobacillus crispatus, Lactobacillus jensenii, and Lactobacillus iners).

133 d by decreased level of Lactobacillus casei, Lactobacillus johnsonii and increased E. coli.

134 and decreasing Lactobacillus salivarius and Lactobacillus johnsonii.

135 that the S-layer glycoprotein from probiotic Lactobacillus kefiri CIDCA 8348 (SLP-8348) is recognized

136 We recently found that the bacterial species Lactobacillus (L.) reuteri reverses social deficits in m

137 of Lactobacillus acidophilus BCMC(R) 12,130, Lactobacillus lactis BCMC(R) 12,451, Lactobacillus casei

138 era Streptococcus, Listeria, Staphylococcus, Lactobacillus, Lactococcus and Leuconostoc do not have P

139 We identified 6 genera (Acinetobacter, Lactobacillus, Lactococcus, Leuconostoc, Saccharomyces a

140 n employed as probiotics, the engineering of Lactobacillus membrane vesicles presents a new avenue fo

141 that eradicated or enriched transmission of Lactobacillus murinus exacerbated and prevented disease,

142 icrobiome in mice, particularly by depleting Lactobacillus murinus.

143 e lungs of mice were dominantly colonized by Lactobacillus murinus.

144 resulted in a low-diversity mCT dominated by Lactobacillus (n = 40), and intermediate-diversity (n =

145 al meconium, with Micrococcaceae (n = 9) and Lactobacillus (n = 6) the most abundant.

146 cant decrease of Bifidobacteria (p .047) and Lactobacillus (p .038) in obese NAFLD patients and a ten

147 Lactobacillus paracasei and Lactobacillus plantarum were

148 The recently isolated Lactobacillus paracasei K5 (a potential probiotic) was i

149 The novel Lactobacillus paracasei K5 strain, recently isolated fro

150 Diet-induced obese animals received either Lactobacillus paracasei NFBC 338 transformed to express

151 tobacillus coryniformis subsp. coryniformis, Lactobacillus paraplantarum were also found.

152 H (P < 0.001) and positively correlated with Lactobacillus/Pediococcus/Leuconostoc spp. (P = 0.001).G

153 tion on Bifidobacterium spp. (P = 0.008) and Lactobacillus/Pediococcus/Leuconostoc spp. (P = 0.018);

154 us/Pediococcus/Leuconostoc spp. (P = 0.018); Lactobacillus/Pediococcus/Leuconostoc spp. decreased in

155 In silico analysis of Lactobacillus pentosus MP-10 plasmids (pLPE-1 to pLPE-5)

156 In the latter case, a Lactobacillus pentosus strain from green olive fermentat

157 a melanogaster, Acetobacter pomorum (Ap) and Lactobacillus plantarum (Lp) a syntrophic relationship i

158 Lactobacillus brevis POM, and Lactobacillus plantarum (TR-7, TR-71, TR-14) were used t

159 igned fermentation by selected autochthonous Lactobacillus plantarum AFI5 and Lactobacillus fabiferme

160 tigated the population dynamics of exogenous Lactobacillus plantarum and its interactions with intest

161 to or even better than the reference strain Lactobacillus plantarum ATCC 14917, was chosen for furth

162 nd linoleic acids were highly metabolized by Lactobacillus plantarum AVEF17, leading to high levels o

163 onal fermented pork production, nham, namely Lactobacillus plantarum BCC9546, was used as an example.

164 tic strains were selected for encapsulation (Lactobacillus plantarum CECT 220 and Lactobacillus casei

165 entation with Lab4 probiotic consortium plus Lactobacillus plantarum CUL66 resulted in significant re

166 The lar operon in Lactobacillus plantarum encodes five Lar proteins (LarA/

167 A Lactobacillus plantarum fermentation product (Bio21B), o

168 reated for 48 h using a commercial strain of Lactobacillus plantarum followed by fermentation using a

169 pithelial integrity, we introduced probiotic Lactobacillus plantarum into Simian immunodeficiency vir

170 The effect of Lactobacillus plantarum isolates from Stilton cheese on

171 e mayonnaise containing free and immobilized Lactobacillus plantarum LBRZ12 cells and essential oils

172 lled trial of an oral synbiotic preparation (Lactobacillus plantarum plus fructooligosaccharide) in r

173 tabolic activity of Lactobacillus plantarum, Lactobacillus plantarum subsp. argentoratensis and Oenoc

174 ow that encapsulating LsLAI in gram-positive Lactobacillus plantarum that is chemically permeabilized

175 lular vesicles (EVs) isolated from probiotic Lactobacillus plantarum to protect tuna fish against spo

176 n previously, administration of immunobiotic Lactobacillus plantarum to the respiratory tracts of PVM

177 Lactobacillus paracasei and Lactobacillus plantarum were dominant, but Leuconostoc m

178 Co-culturing of Lactobacillus plantarum with Acetobacter species altered

179 natural commensals (including the probiotic Lactobacillus plantarum).

180 vesicle production in Staphylococcus aureus, Lactobacillus plantarum, and other Gram-positives has re

181 distinct taxon of the Drosophila microbiota, Lactobacillus plantarum, is capable of stimulating the g

182 aimed to determine the metabolic activity of Lactobacillus plantarum, Lactobacillus plantarum subsp.

183 ation with commercially available strains of Lactobacillus plantarum, originally isolated from fermen

184 mmetry axis of a hexameric enzyme, LarE from Lactobacillus plantarum, was conducted.

185 teria, such as Lactobacillus acidophilus and Lactobacillus plantarum, were evaluated.

186 Supplementing antibiotic-treated mice with a Lactobacillus probiotic before MI restored myeloid cell

187 splantation of monocytes, or dietary SCFA or Lactobacillus probiotic supplementation was conducted to

188 Here, we bioengineered Lactobacillus probiotics (BLP) to express the Listeria a

189 The qPCR-based LbRC ( Lactobacillus Relative Composition) assay predicted BV r

190 significantly higher pre-treatment levels of Lactobacillus relative to bacterial vaginosis-associated

191 Microbiome analysis revealed high amounts of Lactobacillus resp. low amounts of Proteobacteria in SBS

192 days containing either the probiotic strains Lactobacillus reuteri (DSM 17938 and L. reuteri (ATTC PT

193 structure to a previously reported EPS from Lactobacillus reuteri 180.

194 The two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulator

195 We show that prophages of the gut symbiont Lactobacillus reuteri are activated during gastrointesti

196 Parallel bioinformatic approaches identified Lactobacillus reuteri as a commensal species unexpectedl

197 s licheniformis, Escherichia coli JM109, and Lactobacillus reuteri ATCC PTA 4659.

198 ctive in selectively promoting the growth of Lactobacillus reuteri C1 strain as evidenced by the opti

199 effects on the gut microbiota and find that Lactobacillus reuteri can drive autoimmunity but is amel

200 Finally, probiotic supplementation with Lactobacillus reuteri did not impose any phenotypic chan

201 acter lwoffii, Lactobacillus amylovorus, and Lactobacillus reuteri dominated, along with several vira

202 uiz et al. (2019) find that translocation of Lactobacillus reuteri from the gut to systemic organs wo

203 we demonstrated that oral administration of Lactobacillus reuteri in healthy male mice increases bon

204 heat, using 72 h solid-state fermentation by Lactobacillus reuteri K777 and Lb. plantarum K779.

205 Postnatal antibiotic groups received Lactobacillus reuteri probiotic.

206 Colonization of the gut by certain probiotic Lactobacillus reuteri strains has been associated with r

207 nt vivaria, correlating with the presence of Lactobacillus reuteri This species induced DP IELs in ge

208 we screened several bacteria and identified Lactobacillus reuteri to be a promising candidate for ad

209 laning (SRP) with/without adjunct probiotic (Lactobacillus reuteri) treatment towards the reduction i

210 ccus epidermidis) and intestinal microbiota (Lactobacillus reuteri, Enterococcus faecalis, Lactobacil

211 opobium vaginae and decreased frequencies of Lactobacillus reuteri, Lactobacillus crispatus, Lactobac

212 Bifidobacterium animalis subspecies lactis, Lactobacillus reuteri, or Lactobacillus rhamnosus signif

213 tered with or without the supplementation of Lactobacillus rhamnosus (P) to zebrafish in order to exp

214 of bacteria: Lactobacillus rhamnosus B 442, Lactobacillus rhamnosus 1937, and Lactococcus lactis JBB

215 randomized to receive a probiotic containing Lactobacillus rhamnosus and Lactobacillus helveticus or

216 that biofilm formation by Bacillus subtilis, Lactobacillus rhamnosus and Pseudomonas fluorescens indu

217 The following strains of bacteria: Lactobacillus rhamnosus B 442, Lactobacillus rhamnosus 1

218 15 mutants of the preQ(1)-II riboswitch from Lactobacillus rhamnosus demonstrates that ligand binding

219 sein formula (EHCF) containing the probiotic Lactobacillus rhamnosus GG (LGG) can reduce the occurren

220 whether intestinal epithelial cells modulate Lactobacillus rhamnosus GG (LGG) functions, we examined

221 the widely used probiotic and the commensal Lactobacillus rhamnosus GG (LGG) on ENS and GI motility

222 human origin Lactobacillus fermentum SR4 and Lactobacillus rhamnosus GG (LGG) were studied for their

223 apsule containing a probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis

224 , a daily dose of a probiotic combination of Lactobacillus rhamnosus GG and Bifidobacterium animalis

225 ventive intranasal treatment with probiotics Lactobacillus rhamnosus GG and L. rhamnosus GR-1 in a mo

226 its of L lactis subsp cremoris ATCC 19257 or Lactobacillus rhamnosus GG ATCC 53103 (control bacteria)

227 ctive of this study was to determine whether Lactobacillus rhamnosus GG culture supernatant (LCS) has

228 andard yogurt culture and a probiotic strain Lactobacillus rhamnosus GG were used.

229 Lactobacillus rhamnosus L34 attenuated GI leakage in the

230 nic epithelial cells in vitro In conclusion, Lactobacillus rhamnosus L34 attenuated the severity of s

231 We evaluated the therapeutic effects of Lactobacillus rhamnosus L34 in a new sepsis model of ora

232 matory effect of the conditioned medium from Lactobacillus rhamnosus L34 was also demonstrated by the

233 g were used to interrogate the impact of the Lactobacillus rhamnosus R0011 secretome (LrS) on TNF-alp

234 subspecies lactis, Lactobacillus reuteri, or Lactobacillus rhamnosus significantly reduced severe NEC

235 Lactobacillus rhamnosus was administered intranasally ei

236 res of GUS enzymes from human gut commensals Lactobacillus rhamnosus, Ruminococcus gnavus, and Faecal

237 e to the SDR stressor specifically increased Lactobacillus RNA in the spleen, which localized in sple

238 ts of ultrasound (US) frequency, addition of Lactobacillus sakei culture and drying time on key nutri

239 In this work, we study Lactobacillus sakei L-arabinose isomerase (LsLAI) for D-

240 0 angstrom apo crystal structure of BSH from Lactobacillus salivarius (lsBSH).

241 tus and Lactobacillus agilis, and decreasing Lactobacillus salivarius and Lactobacillus johnsonii.

242 im of this study was to assess the effect of Lactobacillus salivarius G60 (LS) and inulin on oral hal

243 presentation of Mucispirillum schaedleri and Lactobacillus salivarius Such modification in flora was

244 via wiggsiae, Parascardovia denticolens, and Lactobacillus salivarius were found almost exclusively i

245 ion of cell-free enzyme extracts (CFEs) from Lactobacillus sanfranciscensis (SF), Hafnia alvei (HF) a

246 etobacter boissieri, Acinetobacter nectaris, Lactobacillus sanfranciscensis, Lactococcus lactis, Lact

247 shows that a critical factor in efficacy is Lactobacillus sequestration of metronidazole, and effica

248 e-specific reagent (ASR) assay adds a second Lactobacillus sp. target, and the recently cleared in vi

249 membrane vesicles (MVs) from three different Lactobacillus species (L. acidophilus ATCC 53544, L. cas

250 red with placebo, a combination of 1 or more Lactobacillus species (spp) and 1 or more Bifidobacteriu

251 red using LAB strains belonging to different Lactobacillus species and changes in phenolic acid, caro

252 al microbiota, characterized by depletion of Lactobacillus species and increased bacterial diversity,

253 Lactobacillus species are beneficial for the functional

254 Given that many Lactobacillus species are Generally Regarded as Safe and

255 We characterize the vesicles from each Lactobacillus species comparing the physiochemical prope

256 Lactobacillus species may protect against HIV partly by

257 vaginal microbial community with paucity of Lactobacillus species was associated with persistent hrH

258 and cervix) microenvironment is dominated by Lactobacillus species, which benefit the host through sy

259 etween devices when compared to those with a Lactobacillus species-dominant VM (p = 0.0049).

260 Both 16S rRNA gene sequencing and Lactobacillus species-specific (L. iners & L crispatus)

261 ly associated with the numbers of indigenous Lactobacillus species.

262 that included Eggerthella lenta and several Lactobacillus species.

263 lity evidence that combinations of 1 or more Lactobacillus spp and 1 or more Bifidobacterium spp and

264 the superiority of combinations of 1 or more Lactobacillus spp and 1 or more Bifidobacterium spp vs s

265 ared with placebo, combinations of 1 or more Lactobacillus spp and 1 or more Bifidobacterium spp, Bif

266 ; pinteraction=0.652); or between those with Lactobacillus spp morphotypes and those without (70.48%

267 alis or Bacteroides spp and non-detection of Lactobacillus spp) as markers of abnormal microbiota.

268 ed with L. iners abundance, though not other Lactobacillus spp.

269 CTL19 showed significantly increased litter Lactobacillus spp. (P < 0.05) compared to other treatmen

270 tion limit was 105CFU/ml in pure culture for Lactobacillus spp. and 120CFU/ml in pure culture for S.

271 Cecal Lactobacillus spp. and Escherichia coli (E. coli) were n

272 trium has a resident microbiota dominated by Lactobacillus spp. and is therefore similar to that of t

273 Lactobacillus spp. depletion and presence of specific an

274 Surprisingly, even in Lactobacillus spp. dominated cervicovaginal microbiota,

275 Lactobacillus spp. positively affect IBS symptoms, altho

276 extent, by Lactobacillus iners, the genital Lactobacillus spp. that predominates in African, Caribbe

277 hylactic administration of some, but not all Lactobacillus spp. was protective, as was administration

278 types are dominated by lactic-acid producing Lactobacillus spp. while the fifth is commonly composed

279 icial bacteria such as Bifidobacterium spp., Lactobacillus spp., Bacteroides acidifaciens, and Bacter

280 rmented with indigenous probiotic strains of Lactobacillus spp., compared with fermented bovine milk.

281 udy in humans reduced intestinal survival of Lactobacillus spp., increased TH17 cells and increased b

282 The vaginal microbiota, dominated by Lactobacillus spp., plays a key role in preventing HIV-1

283 ceae and increased the relative abundance of Lactobacillus spp., two groups of bacteria previously sh

284 gration of the corresponding genes into this Lactobacillus strain may contribute to the prevention of

285 c administration or feeding with a probiotic Lactobacillus strain partially rescues the behavioral, l

286 characterize the proteolytic activity of 170 Lactobacillus strains isolated from traditional Mongolia

287 Mice were also treated with Lactobacillus strains that had high or low ATI-degrading

288 fed ATIs for 1 week were gavaged daily with Lactobacillus strains that had high or low ATI-degrading

289 al prevalent and pig-specific species within Lactobacillus, Streptococcus, Clostridium, Desulfovibrio

290 undances of Bacilli species including genera Lactobacillus, Streptococcus, Enterococcus, and Listeria

291 aintaining elevated kynurenine levels during Lactobacillus supplementation diminished the treatment b

292 the amount of fecal Salmonella bacteria with Lactobacillus treatment was demonstrated.

293 rtion of lactate-producing bacteria (such as Lactobacillus, Turicibacter and Streptococcus) were foun

294 Some species associated with non-Lactobacillus vaginal microbiota may trigger immune resp

295 ic (L. iners & L crispatus) qPCR showed that Lactobacillus was rare in the endometrium.

296 ibiotics; potentially protective Blautia and Lactobacillus were higher in patients who did not receiv

297 in alcoholic beverages, whereas Bacillus and Lactobacillus were the dominant genera in the locust bea

298 In this study, ten strains of Lactobacillus were used to assess the in vitro metabolis

299 We found ATIs to be degraded by Lactobacillus, which reduced the inflammatory effects of

300 etectible mucosal tenofovir was lower in non-Lactobacillus women, negatively correlating with G. vagi